 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 December 1998 | Volume 129 Issue 11 Part 2 | Pages 925-931
If untreated, hemochromatosis can cause serious illness and early death, but the disease is still substantially under-diagnosed. The cornerstone of screening and case detection is the measurement of serum transferrin saturation and the serum ferritin level. Once the diagnosis is suspected, physicians must use serum ferritin levels and hepatic iron stores on liver biopsy specimens to assess patients for the presence of iron overload. Liver biopsy is also used to establish the presence or absence of cirrhosis, which can affect prognosis and management. A DNA-based test for the HFE gene is commercially available, but its place in the diagnosis of hemochromatosis is still being evaluated. Currently, the most useful role for this test is in the detection of hemochromatosis in the family members of patients with a proven case of the disease. It is crucial to diagnose hemochromatosis before hepatic cirrhosis develops because phlebotomy therapy can avert serious chronic disease and can even lead to normal life expectancy.
Author and Article Information
From the University of Queensland, Brisbane, Australia; the Centers for Disease Control and Prevention, Atlanta, Georgia; and the University of Washington, Seattle, Washington.
DIAGNOSIS AND MANAGEMENT
Diagnosis of Hemochromatosis
Note: This article is one of a series of articles comprising an Annals of Internal Medicine supplement entitled "Iron Overload, Public Health, and Genetics." To view a complete list of the articles included in this supplement, please view its Table of Contents.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  K. Kalantar-Zadeh, K. Kalantar-Zadeh, and G. H. Lee The Fascinating but Deceptive Ferritin: To Measure It or Not to Measure It in Chronic Kidney Disease? Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(Supplement_1): S9 - S18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Whitlock, B. A. Garlitz, E. L. Harris, T. L. Beil, and P. R. Smith Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med, August 1, 2006; 145(3): 209 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Swinkels, M. C.H. Janssen, J. Bergmans, and J. J.M. Marx Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches Clin. Chem., June 1, 2006; 52(6): 950 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-U. Hahn, M. Steiner, S. Bochnig, H. Schmidt, P. Schuff-Werner, and W. Kerner Evaluation of a Diagnostic Algorithm for Hereditary Hemochromatosis in 3,500 Patients With Diabetes Diabetes Care, February 1, 2006; 29(2): 464 - 466. [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Blanck, M. E Cogswell, C. Gillespie, and M. Reyes Iron supplement use and iron status among US adults: results from the third National Health and Nutrition Examination Survey Am. J. Clinical Nutrition, November 1, 2005; 82(5): 1024 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schmitt, R. M. Golub, and R. Green Screening Primary Care Patients for Hereditary Hemochromatosis with Transferrin Saturation and Serum Ferritin Level: Systematic Review for the American College of Physicians Ann Intern Med, October 4, 2005; 143(7): 522 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Alustiza, J. Artetxe, A. Castiella, C. Agirre, J. I. Emparanza, P. Otazua, M. Garcia-Bengoechea, J. Barrio, F. Mujica, and J. A. Recondo MR Quantification of Hepatic Iron Concentration Radiology, February 1, 2004; 230(2): 479 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Blanck, C. M. Pfeiffer, S. P. Caudill, M. Reyes, E. W. Gunter, G. Imperatore, O. W. van Assendelft, S. Strider, and T. Dearth Serum Iron and Iron-binding Capacity: A Round-Robin Interlaboratory Comparison Study Clin. Chem., October 1, 2003; 49(10): 1672 - 1675. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Scotet, M.-C. Merour, A.-Y. Mercier, B. Chanu, T. Le Faou, O. Raguenes, G. Le Gac, C. Mura, J.-B. Nousbaum, and C. Ferec Hereditary Hemochromatosis: Effect of Excessive Alcohol Consumption on Disease Expression in Patients Homozygous for the C282Y Mutation Am. J. Epidemiol., July 15, 2003; 158(2): 129 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Chitambar and J. P. Wereley Expression of the Hemochromatosis (HFE) Gene Modulates the Cellular Uptake of 67Ga J. Nucl. Med., June 1, 2003; 44(6): 943 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J K Limdi and G M Hyde Evaluation of abnormal liver function tests Postgrad. Med. J., June 1, 2003; 79(932): 307 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Morrison, D. J. Brandhagen, P. D. Phatak, J. C. Barton, E. L. Krawitt, H. B. El-Serag, S. C. Gordon, M. V. Galan, B. Y. Tung, G. N. Ioannou, et al. Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis Ann Intern Med, April 15, 2003; 138(8): 627 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T Sempos Do body iron stores increase the risk of developing coronary heart disease? Am. J. Clinical Nutrition, September 1, 2002; 76(3): 501 - 503. [Full Text] [PDF]
|
|
|
|
 |
|
 E Ryan, V Byrnes, B Coughlan, A-M Flanagan, S Barrett, J C O'Keane, and J Crowe Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration? Gut, July 1, 2002; 51(1): 108 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Girouard, Y. Giguere, R. Delage, and F. Rousseau Prevalence of HFE gene C282Y and H63D mutations in a French-Canadian population of neonates and in referred patients Hum. Mol. Genet., January 1, 2002; 11(2): 185 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Siek, J. Lawlor, D. Pelczar, M. Sane, and J. Musto Direct Serum Total Iron-binding Capacity Assay Suitable for Automated Analyzers Clin. Chem., January 1, 2002; 48(1): 161 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Lloyd, V. F. Reyna, and P. Whalen Accuracy and Ambiguity in Counseling Patients About Genetic Risk Arch Intern Med, November 12, 2001; 161(20): 2411 - 2413. [Full Text] [PDF]
|
|
|
|
 |
|
 D. O'Toole, E. J. Kelly, M. M. McAllister, A. W. Layton, R. W. Norrdin, W. C. Russell, K. Saeb-Parsy, and A. P. Walker Hepatic Failure and Hemochromatosis of Salers and Salers-cross Cattle Vet. Pathol., July 1, 2001; 38(4): 372 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Steinberg, M. E. Cogswell, J. C. Chang, S. P. Caudill, G. M. McQuillan, B. A. Bowman, L. M. Grummer-Strawn, E. J. Sampson, M. J. Khoury, and M. L. Gallagher Prevalence of C282Y and H63D Mutations in the Hemochromatosis (HFE) Gene in the United States JAMA, May 2, 2001; 285(17): 2216 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Chitambar and J. P. Wereley Iron transport in a lymphoid cell line with the hemochromatosis C282Y mutation Blood, May 1, 2001; 97(9): 2734 - 2740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Beard Iron status of free-living elderly individuals Am. J. Clinical Nutrition, March 1, 2001; 73(3): 503 - 504. [Full Text] [PDF]
|
|
|
|
|
|
N E Hellman, M Schaefer, S Gehrke, P Stegen, W J Hoffman, J D Gitlin, and W Stremmel Hepatic iron overload in aceruloplasminaemia Gut, December 1, 2000; 47(6): 858 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J Seamark, M. Hutchinson, I. Heath, and M F McMullin Controversy in primary care: Should asymptomatic haemochromatosis be treated? Treatment can be onerous for patient and doctor Commentary: False certainty of clinical guidance Commentary: Early treatment is essential BMJ, May 13, 2000; 320(7245): 1314 - 1317. [Full Text]
|
|
|
|
 |
|
 D. S. Pratt and M. M. Kaplan Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients N. Engl. J. Med., April 27, 2000; 342(17): 1266 - 1271. [Full Text] [PDF]
|
|
|
|
|
|
H. B. El-Serag, J. M. Inadomi, and K. V. Kowdley Screening for Hereditary Hemochromatosis in Siblings and Children of Affected Patients: A Cost-Effectiveness Analysis Ann Intern Med, February 15, 2000; 132(4): 261 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kalantar-Zadeh and F. C. Luft Diagnosis of Hemochromatosis Ann Intern Med, August 17, 1999; 131(4): 311 - 311. [Full Text] [PDF]
|
|
|
|
|
|
A. L. Franks and W. Burke Will the Real Hemochromatosis Please Stand Up? Ann Intern Med, June 15, 1999; 130(12): 1018 - 1019. [Full Text] [PDF]
|
|
|
|
|
|
S. M. McDonnell, P. D. Phatak, V. Felitti, A. Hover, and G. D. McLaren Screening for Hemochromatosis in Primary Care Settings Ann Intern Med, December 1, 1998; 129(11_Part_2): 962 - 970. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Cogswell, S. M. McDonnell, M. J. Khoury, A. L. Franks, W. Burke, and G. Brittenham Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening Ann Intern Med, December 1, 1998; 129(11_Part_2): 971 - 979. [Abstract] [Full Text]
|
|
|
|
|
|
S. F. Wetterhall, M. E. Cogswell, and K. V. Kowdley Public Health Surveillance for Hereditary Hemochromatosis Ann Intern Med, December 1, 1998; 129(11_Part_2): 980 - 986. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. McDonnell, D. L. Witte, M. E. Cogswell, and R. McIntyre Strategies To Increase Detection of Hemochromatosis Ann Intern Med, December 1, 1998; 129(11_Part_2): 987 - 992. [Abstract] [Full Text]
|
|
Article
